C. de los Reyes et al. / Phytochemistry 102 (2014) 152–161
159
respectively) using solvents of increasing polarities starting with
(7Z,9E,13Z)-11-hydroxyhexadeca-7,9,13-trienoic acid (11-HHT) (6)
the combinations of hexanes-Et2O (9:1, 1:1, 3:7, v/v, 1.5 L each),
Et2O 100% (3.0 L), some combinations of CHCl3–MeOH (9:1 and
8:2, v/v, 1.5 L each), and finally MeOH 100% (1.5 L). The fractions
eluted with hexanes-Et2O (3:7, v/v), Et2O 100%, and CHCl3–MeOH
(9:1, 8:2, v/v) were dried and resuspended in MeOH–H2O (9:1,
v/v, 50 mg/mL), transferred onto RP-18 cartridges preconditioned
with MeOH-H2O (9:1, v/v, 1 mL) and eluted with 10 mL of the same
solvent. After evaporation of the solvent, each mixture was repeat-
edly separated by normal phase HPLC using CHCl3–MeOH
(99.8:0.2, v/v) or hexanes-propan-2-ol-AcOH (97:3:0.1, v/v/v) as
the mobile phase until pure compounds were obtained. The extract
of ITC09-0902-12 yielded dry wt. of compounds 1 (1.6 ꢁ 10ꢀ2% dry
Colorless oil; [a]
D = +6.7 (c 0.06, MeOH); 1H NMR (CD3OD,
600 MHz) see Table 1; 13C NMR (CD3OD, 150 MHz) see Table 1;
HRESIMS(ꢀ) m/z 265.1809 [MꢀH]ꢀ (calcd for C16H25O3, 265.1804).
(5Z,9Z,11E,15Z)-13-hydroxyoctadeca-5,9,11,15-tetraenoic acid (7)
Colorless oil; [a]D = +7.1 (c 0.07, MeOH); IR (film) mmax 3416,
1700, 1580, 1406; 1H NMR (CD3OD, 600 MHz) see Table 3; 13C
NMR (CD3OD, 150 MHz) see Table 3; HRESIMS(ꢀ) m/z 291.1956
[MꢀH]ꢀ (calcd for C18H27O3, 291.1960).
(5Z,9Z,11E)-13-hydroxyoctadeca-5,9,11-trienoic acid (8)
Colorless oil; 1H NMR (CD3OD, 500 MHz) see Table 3; 13C NMR
(CD3OD, 125 MHz) see Table 3; HRESIMS(ꢀ) m/z 293.2115 [MꢀH]ꢀ
(calcd for C18H29O3, 293.2117).
wt.),
3
(1.1 ꢁ 10ꢀ3
%
dry wt.),
4
(1.3 ꢁ 10ꢀ3
%
dry wt.),
5
%
(2.1 ꢁ 10ꢀ3% dry wt.), 9 (9.5 ꢁ 10ꢀ3% dry wt.), 11 (8.1 ꢁ 10ꢀ3
dry wt.), 12 (2.4 ꢁ 10ꢀ3% dry wt.), 13 (8.6 ꢁ 10ꢀ3% dry wt.), and
14 (4.2 ꢁ 10ꢀ4% dry wt.). The extract of ITC09-1702-12 yielded
compounds 1 (4.8 ꢁ 10ꢀ3% dry wt.), 2 (3.1 ꢁ 10ꢀ3% dry wt.), 6
(1.1 ꢁ 10ꢀ3% dry wt.), 7 (2.0 ꢁ 10ꢀ3% dry wt.), 8 (6.6 ꢁ 10ꢀ4% dry
(5Z,8Z,11Z,13E,15S,17Z)-15-hydroxyeicosa-5,8,11,13,17-pentaenoic
acid (15S-HEPE) (15)
(1.7 ꢁ 10ꢀ2
%
dry wt.), 10 (4.7 ꢁ 10ꢀ4
% dry wt.), 11
Colorless oil; [
a]D = +4.9 (c 0.11, MeOH); IR (film) mmax 3417,
wt.),
9
1700, 1595, 1432 cmꢀ1
;
1H NMR (CD3OD, 600 MHz) see Table 3;
(2.6 ꢁ 10ꢀ3% dry wt.), 12 (1.5 ꢁ 10ꢀ3% dry wt.), 13 (1.5 ꢁ 10ꢀ3
%
13C NMR (CD3OD, 150 MHz) see Table 3; HRESIMS(ꢀ) m/z
dry wt.), and 14 (3.5 ꢁ 10ꢀ3% dry wt.). Extraction of the lyophi-
lized biomass of N. gaditana (25 g) as described above yielded
7.0 g of extract, that was chromatographed on a silica gel col-
umn (28 ꢁ 3.5 cm) using solvents of increasing polarities starting
with the combinations of hexanes-Et2O (9:1, 1:1, 3:7, v/v,
0.5 L each), Et2O 100% (0.2 L), some combinations of CHCl3–
MeOH (9:1 and 8:2, v/v, 0.2 and 0.4 L, respectively), and finally
MeOH 100% (0.3 L). The fractions eluted with hexanes-Et2O
(3:7, v/v), Et2O 100%, and CHCl3–MeOH (9:1, 8:2, v/v) were
317.2123 [MꢀH]ꢀ (calcd for C20H29O3, 317.2117).
Synthesis of the MPA esters 1r, 1s, 15r, 15s
The acid (1 or 15) was dissolved in MeOH (1 mL) and treated
with a solution of TMSCH2N2 2.0 M in Et2O (100 lL). After stirring
the mixture at room temp. for 30 min, the solvent was evaporated.
Treatment of 1 (2.8 mg, 0.011 mmol) and 15 (7.1 mg, 0.022 mmol)
as described above yielded the methyl esters 1a and 15a, respec-
tively, with quantitative yield in both cases. Each methyl ester
was dissolved in CH2Cl2 (0.5 mL) and treated with CH2Cl2 solutions
(0.5 mL each) of N,N0-dicyclohexylcarbodiimide (tenfold excess
over the starting compound), N,N-dimethylaminopyridine (fivefold
excess) and the MPA acid (fivefold excess). The mixture was stirred
overnight at room temp. and then purified by preparative TLC
(hexanes-EtOAc 85:15, v/v) to obtain the MPA ester. Treatment
of 1a (1.6 mg, 5.8 ꢁ 10ꢀ3 mmol) and 15a (5.4 mg, 1.6 ꢁ 10ꢀ2
mmol) with (R)-MPA as described above yielded compounds 1r
and 15r, respectively. Treatment of 1a (1.2 mg, 4.3 ꢁ 10ꢀ3 mmol)
and 15a (1.7 mg, 5.1 ꢁ 10ꢀ3 mmol) with (S)-MPA as described
above yielded compounds 1s and 15s, respectively.
separated as described above to yield compound 15 (6.0 ꢁ 10ꢀ2
%
dry wt.).
Characterization of compounds
(4Z,7Z,9E,11S,13Z)-11-hydroxyhexadeca-4,7,9,13-tetraenoic acid (1)
Colorless oil; [ D = +7.5 (c 0.08, MeOH); IR (film) mmax 3452,
1711, 1591, 1411 cmꢀ1
a
]
;
1H NMR (CD3OD, 600 MHz) see Table 1;
13C NMR (CD3OD, 150 MHz) see Table 1; HRESIMS(ꢀ) m/z
263.1647 [MꢀH]ꢀ (calcd for C16H23O3, 263.1647).
Compound 1r: 1H NMR (CDCl3, 600 MHz) (selected data, assign-
ments aided by a COSY experiment) d 6.51 (1H, dd, J = 15.3 and
11.2 Hz, H-9), 5.94 (1H, dd, J = 11.4 and 11.2 Hz, H-8), 5.61 (1H,
dd, J = 15.3 and 7.3 Hz, H-10), 5.41 (1H, m, H-7), 5.38 (1H, m, H-
11), 5.34 (1H, m, H-14), 5.03 (1H, m, H-13), 2.91 (2H, br dd,
J = 6.2 and 5.9 Hz, H2-6), 2.32 (1H, m, H-12a), 2.26 (1H, m, H-
12b), 1.91 (2H, qd, J = 7.6 and 7.6 Hz, H2-15), 0.88 (3H, t,
J = 7.5 Hz, Me-16).
(4Z,7E,9E,13Z)-11-hydroxyhexadeca-4,7,9,13-tetraenoic acid (2)
Colorless oil; [a]
D = +12.0 (c 0.10, MeOH); 1H NMR (CD3OD,
500 MHz) see Table 1; 13C NMR (CD3OD, 125 MHz) see Table 1;
HRESIMS(ꢀ) m/z 263.1646 [MꢀH]ꢀ (calcd for C16H23O3,
263.1647).
(4Z,6E,10Z,13Z)-8-hydroxyhexadeca-4,6,10,13-tetraenoic acid (3)
Colorless oil; 1H NMR (CD3OD, 500 MHz) see Table 2; 13C NMR
(CD3OD, 125 MHz) see Table 2; HRESIMS(ꢀ) m/z 263.1644 [MꢀH]ꢀ
(calcd for C16H23O3, 263.1647).
Compound 1s: 1H NMR (CDCl3, 600 MHz) (selected data, assign-
ments aided by a COSY experiment) d 6.27 (1H, dd, J = 15.2 and
10.9 Hz, H-9), 5.85 (1H, dd, J = 11.2 and 10.9 Hz, H-8), 5.50 (1H,
dd, J = 15.2 and 6.5 Hz, H-10), 5.48 (1H, m, H-14), 5.40 (1H, m, H-
11), 5.32 (1H, m, H-7), 5.25 (1H, m, H-13), 2.76 (2H, br dd, J = 7.3
and 7.0 Hz, H2-6), 2.44 (1H, m, H-12a), 2.35 (1H, m, H-12b), 2.03
(2H, m, H2-15), 0.95 (3H, t, J = 7.6 Hz, Me-16).
(4Z,8E,10Z,13Z)-7-hydroxyhexadeca-4,8,10,13-tetraenoic acid (4)
Colorless oil; 1H NMR (CD3OD, 500 MHz) see Table 2; 13C NMR
(CD3OD, 125 MHz) see Table 2; HRESIMS(ꢀ) m/z 263.1649 [MꢀH]ꢀ
(calcd for C16H23O3, 263.1647).
Compound 15r: 1H NMR (CDCl3, 600 MHz) (selected data,
assignments aided by a COSY experiment) d 6.51 (1H, dd, J = 15.1
and 11.0 Hz, H-13), 5.94 (1H, dd, J = 11.0 and 10.7 Hz, H-12), 5.61
(1H, dd, J = 15.1 and 7.3 Hz, H-14), 5.34 (1H, m, H-15), 5.33 (1H,
m, H-18), 5.03 (1H, dddd, J = 14.2, 7.2, 3.2, and 1.6 Hz, H-17),
2.91 (2H, dd, J = 7.3 and 7.3 Hz, H2-10), 2.29 (1H, m, H-16a), 2.26
(1H, ddd, J = 14.5, 7.3, and 7.3 Hz, H-16b), 1.91 (2H, m, H2-19),
0.88 (3H, t, J = 7.4 Hz, Me-20).
(5E,7Z,10Z,13Z)-4-hydroxyhexadeca-5,7,10,13-tetraenoic acid (5)
Colorless oil; 1H NMR (CD3OD, 500 MHz) see Table 2; 13C NMR
(CD3OD, 125 MHz) see Table 2; HRESIMS(ꢀ) m/z 263.1649 [MꢀH]ꢀ
(calcd for C16H23O3, 263.1647).